It is known that the aberrant activation of NF-κB signaling upregulates the expression of these prosurvival molecules and provides enabling cues against TGF-β-mediated cell death in hepatoma cells [181,182]. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.